Algorhythm Holdings, Inc.RIMEEarnings & Financial Report
Algorhythm Holdings, Inc. is a technology firm that develops AI-powered clinical decision support solutions for the healthcare industry. It primarily caters to healthcare providers across North America, with tools aimed at improving patient care quality, streamlining clinical workflows, and cutting operational costs for medical institutions.
Revenue
$15.9M
Gross Profit
$3.7M
Operating Profit
$106.0K
Net Profit
$97.5K
Gross Margin
23.4%
Operating Margin
0.7%
Net Margin
0.6%
YoY Growth
-6.9%
EPS
$0.03
Algorhythm Holdings, Inc. Q3 FY2023 Financial Summary
Algorhythm Holdings, Inc. reported revenue of $15.9M (down 6.9% YoY) for Q3 FY2023, with a net profit of $97.5K (down 67.1% YoY) (0.6% margin). Cost of goods sold was $12.2M, operating expenses totaled $3.6M.
Key Financial Metrics
| Total Revenue | $15.9M |
|---|---|
| Net Profit | $97.5K |
| Gross Margin | 23.4% |
| Operating Margin | 0.7% |
| Report Period | Q3 FY2023 |
Algorhythm Holdings, Inc. Quarterly Revenue & Net Profit History
Algorhythm Holdings, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $-2.1M | +56.1% | $-3.5M | 169.1% |
| Q2 FY2025 | $2.7M | +11.3% | $-809.0K | -29.8% |
| Q4 FY2024 | $-4.7M | — | $-16.0M | 340.0% |
| Q2 FY2024 | $2.4M | -7.0% | $-6.1M | -250.8% |
| Q1 FY2024 | $2.4M | — | $-2.4M | -97.6% |
| Q3 FY2023 | $15.9M | -6.9% | $97.5K | 0.6% |
| Q2 FY2023 | $2.6M | -77.5% | $-2.5M | -93.7% |
| Q4 FY2022 | $7.1M | -66.5% | $-1.9M | -27.2% |
Income Statement
| Q4 2022 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q2 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1M | $2.6M | $15.9M | $2.4M | $2.4M | $-4.7M | $2.7M | $-2.1M |
| YoY Growth | -66.5% | -77.5% | -6.9% | N/A | -7.0% | N/A | 11.3% | 56.1% |
Balance Sheet
| Q4 2022 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q2 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $24.2M | $15.0M | $32.6M | $19.9M | $12.4M | $18.3M | $12.7M | $12.7M |
| Liabilities | $11.0M | $5.5M | $22.9M | $14.7M | $13.2M | $28.8M | $9.9M | $14.6M |
| Equity | $13.2M | $9.5M | $9.7M | $5.2M | $-872000 | $-10.5M | $2.8M | $-1.9M |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q2 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-2.5M | $1.4M | $-2.6M | $-2.9M | $-1.5M | $-2.3M |